ACE2 is highly expressed at the site of insulin production in the pancreas—decreased insulin secretion and altered glucose tolerance are associated with ACE2 deletion (34)—and diabetes has been identified as a unique comorbidity of COVID-19 (28). Here, ACE2 is linked to COVID-19.